search
Documents
Next-level Sensitivity for the Quantification of Warfarin and Furosemide in Human Plasma
In this application, Warfarin and Furosemide were extracted from human plasma and quantified using a negative ion mode approach on the SCIEX 7500 system and a Kinetex C18 core-shell LC column. The improved front-end technology of the column and system enabled greater ion generation, capture and transmission to improve sensitivity for routine bioanalysis.
Next-level Sensitivity for the Quantification of Warfarin and Furosemide in Human Plasma
In this application, Warfarin and Furosemide were extracted from human plasma and quantified using a negative ion mode approach on the SCIEX 7500 system and a Kinetex C18 core-shell LC column. The improved front-end technology of the column and system enabled greater ion generation, capture and transmission to improve sensitivity for routine bioanalysis.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phases:
Next-level Sensitivity for the Quantification of Warfarin and Furosemide in Human Plasma
In this application, Warfarin and Furosemide were extracted from human plasma and quantified using a negative ion mode approach on the SCIEX 7500 system and a Kinetex C18 core-shell LC column. The improved front-end technology of the column and system enabled greater ion generation, capture and transmission to improve sensitivity for routine bioanalysis.
| Target Industries: | Pharmaceutical |
| Techniques: | HPLC |
| Brands: | Kinetex |
| Separation Modes: | Reversed Phase |
| Phases: | Kinetex C18 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.